Puerto Rico vs Saint Barthélemy: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Puerto Rico
0.2%
in 2024
Saint Barthélemy
0.2%
in 2024
Puerto Rico rank
98th
Saint Barthélemy rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Puerto Rico
- Saint Barthélemy
How they compare
Puerto Rico currently reports 0.2% against 0.2% in Saint Barthélemy, a difference of 0.0%.
Across all 10 years both countries report, Saint Barthélemy has been ahead every year.
Puerto Rico ranks 98th and Saint Barthélemy ranks 98th of 246 countries.
Head to head by decade
| Decade | Puerto Rico | Saint Barthélemy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Puerto Rico or Saint Barthélemy?
- Puerto Rico, at 0.2% against 0.2% in Saint Barthélemy as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Puerto Rico and Saint Barthélemy?
- 0.0%, with Puerto Rico ahead.
- How many years of comparable data are there for Puerto Rico and Saint Barthélemy?
- 10 years are reported by both, from 2015 to 2024.
- How do Puerto Rico and Saint Barthélemy rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Puerto Rico ranks 98th and Saint Barthélemy ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.